Mental disorders including depression and anxiety are continuously rising their prevalence across the globe. Early-life experience of individuals emerges as a main risk factor contributing to the developmental vulnerability to psychiatric disorders. That is, perturbing environmental conditions during neurodevelopmental stages can have detrimental effects on adult mood and emotional responses. However, the possible maladaptive neural mechanisms contributing to such psychopathological phenomenon still remain poorly understood. In this review, we explore preclinical rodent models of developmental vulnerability to psychiatric disorders, focusing on the impact of early-life environmental perturbations on behavioral aspects relevant to stress-rel...
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for the treatment of depressio...
Serotonin is an important neurotransmitter that regulates a range of processes within the brain and ...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
Increasing evidence suggests that anxiety and depression disorders have neurodevelopmental roots, wi...
Risk for adult psychiatric disorders is partially determined by early-life alterations occurring dur...
Selective serotonin reuptake inhibitor (SSRI) antidepressants are the mainstay treatment for the 10–...
Selective serotonin reuptake inhibitor (SSRI) antidepressants are the mainstay treatment for the 10–...
Development passes through sensitive periods, during which plasticity allows for genetic and environ...
One of the most challenging questions in neurobiology to tackle is how the serotonergic system steer...
Most neuropsychiatric disorders have developmental origins and an emerging model postulates that suc...
AbstractMajor depressive disorder (MDD) is one of the most debilitating psychiatric diseases, affect...
Stress has been shown to influence neuroplasticity and is suspected to increase the risk for psychia...
Large numbers of women undergo antidepressant treatment during pregnancy; however, long-term consequ...
Rationale: Given the high prevalence and large burden of psychiatric disorders it is imperative to d...
Rationale: Given the high prevalence and large burden of psychiatric disorders it is imperative to d...
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for the treatment of depressio...
Serotonin is an important neurotransmitter that regulates a range of processes within the brain and ...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
Increasing evidence suggests that anxiety and depression disorders have neurodevelopmental roots, wi...
Risk for adult psychiatric disorders is partially determined by early-life alterations occurring dur...
Selective serotonin reuptake inhibitor (SSRI) antidepressants are the mainstay treatment for the 10–...
Selective serotonin reuptake inhibitor (SSRI) antidepressants are the mainstay treatment for the 10–...
Development passes through sensitive periods, during which plasticity allows for genetic and environ...
One of the most challenging questions in neurobiology to tackle is how the serotonergic system steer...
Most neuropsychiatric disorders have developmental origins and an emerging model postulates that suc...
AbstractMajor depressive disorder (MDD) is one of the most debilitating psychiatric diseases, affect...
Stress has been shown to influence neuroplasticity and is suspected to increase the risk for psychia...
Large numbers of women undergo antidepressant treatment during pregnancy; however, long-term consequ...
Rationale: Given the high prevalence and large burden of psychiatric disorders it is imperative to d...
Rationale: Given the high prevalence and large burden of psychiatric disorders it is imperative to d...
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for the treatment of depressio...
Serotonin is an important neurotransmitter that regulates a range of processes within the brain and ...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...